We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
+$847M
Cap. Flow
+$1.01B
Cap. Flow %
15.59%
Top 10 Hldgs %
14.48%
Holding
1,654
New
595
Increased
238
Reduced
232
Closed
414

Sector Composition

Rank Sector Weight
1 Healthcare 2.4%
2 Technology 1.47%
3 Consumer Discretionary 1.45%
4 Financials 1.41%
5 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ON icon
1101
ON Semiconductor
ON
$31.8B
$186K ﹤0.01%
2,000
-15,800
-89% -$1.53M
CIO
1102
DELISTED
City Office REIT
CIO
$186K ﹤0.01%
+43,693
New +$224K
GSK icon
1103
CALL
GSK
GSK
$104B
$181K ﹤0.01%
+5,000
New +$177K
DXCM icon
1104
DexCom
DXCM
$31.5B
$181K ﹤0.01%
1,936
-13,064
-87% -$1.47M
CTSH icon
1105
Cognizant
CTSH
$24.9B
$176K ﹤0.01%
2,600
+369
+17% +$25.5K
PCG icon
1106
PG&E
PCG
$38.3B
$175K ﹤0.01%
+10,875
New +$187K
PLRX icon
1107
Pliant Therapeutics
PLRX
$64.4M
$173K ﹤0.01%
10,000
-5,000
-33% -$86.7K
CCJ icon
1108
Cameco
CCJ
$37.6B
$171K ﹤0.01%
+4,307
New +$152K
BGS icon
1109
PUT
B&G Foods
BGS
$287M
$169K ﹤0.01%
17,100
HBI
1110
DELISTED
Hanesbrands
HBI
$168K ﹤0.01%
+42,500
New +$206K
ABOS icon
1111
CALL
Acumen Pharmaceuticals
ABOS
$155M
$166K ﹤0.01%
+40,000
New +$247K
ABOS icon
1112
Acumen Pharmaceuticals
ABOS
$155M
$166K ﹤0.01%
+40,000
New +$247K
ABOS icon
1113
PUT
Acumen Pharmaceuticals
ABOS
$155M
$166K ﹤0.01%
+40,000
New +$247K
IMVT icon
1114
Immunovant
IMVT
$7.93B
$164K ﹤0.01%
+4,282
New +$96.8K
BUR icon
1115
Burford Capital
BUR
$903M
$161K ﹤0.01%
11,500
-3,500
-23% -$47.7K
BLUE
1116
CALL
DELISTED
bluebird bio
BLUE
$152K ﹤0.01%
2,500
BLUE
1117
PUT
DELISTED
bluebird bio
BLUE
$152K ﹤0.01%
2,500
BE icon
1118
Bloom Energy
BE
$60.6B
$151K ﹤0.01%
+11,400
New +$179K
MACK
1119
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$150K ﹤0.01%
+12,200
New +$148K
XIFR
1120
XPLR Infrastructure LP
XIFR
$1.12B
$149K ﹤0.01%
+5,000
New +$253K
VTRS icon
1121
PUT
Viatris
VTRS
$20.4B
$148K ﹤0.01%
15,000
SPCE icon
1122
CALL
Virgin Galactic
SPCE
$328M
$144K ﹤0.01%
4,000
RCUS icon
1123
Arcus Biosciences
RCUS
$3.55B
$144K ﹤0.01%
+8,000
New +$161K
TSAT icon
1124
CALL
Telesat
TSAT
$567M
$143K ﹤0.01%
+10,000
New +$136K
FTAI icon
1125
FTAI Aviation
FTAI
$21.1B
$142K ﹤0.01%
3,992
-84,588
-95% -$2.91M

Similar funds

Caption Management's Q3 2023 Portfolio in Review

As of Q3 2023, Caption Management held 1,654 positions worth $6.49B, up 15% from $5.65B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management deployed $1.01B of net new capital in Q3 2023, opening 595 new positions and adding to 238 existing holdings. Its largest new stake was Citigroup: 1,727,200 shares worth $71M.

By sector, the portfolio is most concentrated in Healthcare at 2.4% of assets, down from 2.6% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Spectrum Brands, an estimated $12.2M trimmed.

  • Caption Management's largest Q3 2023 buy was Citigroup: 1,727,200 shares worth $71M.
  • Caption Management added most to Lockheed Martin in Q3 2023, an estimated $17.5M increase.
  • Caption Management's biggest Q3 2023 reduction was Spectrum Brands, cutting an estimated $12.2M.
  • Caption Management fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $20.2M.
  • Caption Management's ten largest holdings make up 14% of its $6.49B portfolio in Q3 2023.
  • Caption Management opened 595 new positions and closed 414 in Q3 2023.
  • Caption Management's portfolio value rose 15% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q3 2023, filed 14 Nov 2023.